Dieffenbachstraße 1
10967 Berlin
Phone:
030-130-10
Fax:
030-13022-0005
Mail:
ed.setnaviv@ofni
Das interdiziplinäre Team besteht aus Gynäkologen, Radiologen, Strahlentherapeuten, Internistischen Onkologen, Pathologen und Psychotherapeuten. Das Vivantes Brustzentrum ist nach den Kriterien der Dt. Krebsgesellschaft / Dt. Gesellschaft für Senologie und ISO Norm 9001 zertifiziert.
Quantity performed | 92 |
Exception? | No exception |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 92 |
Quantity forecast year: | 111 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 795 |
Quantity forecast year: | 761 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
No. | Explanation |
---|---|
CQ30 | Quality assurance guideline for interstitial LDR brachytherapy for low-risk localized prostate cancer (effective January 8, 2021). |
CQ25 | Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V |
Number | Group |
---|---|
144 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
95 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
75 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.
Training of employees on AMTS related topics
Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children
Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)
Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)
Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)
Electronic documentation of the administration of drugs
FL09 - Doctoral supervision
FL02 - Lectureships / teaching posts at universities of applied sciences
FL01 - Lectureships / teaching posts at colleges and universities
FL08 - Editors of scientific journals/textbooks
FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies
FL04 - Project-related cooperation with colleges and universities
FL03 - Student training (clinical traineeship / internship year)
nur Phase-II-Studien
FL06 - Participation in multi-centre phase III/IV studies
seit April 2022
seit April 2021, seit 2023 neue Bundesgesetzgebung in Umsetzung
ab 2022, neue Bundesgesetzgebung umgesetzt
seit Oktober 2022
seit Oktober 2021, Studium mit der Universität der Charité Berlin
seit Februar 2023, neue Bundesgesetzgebung umgesetzt
ab 2022, Bundesgesetzgebung umgesetzt
seit Oktober 2021
seit 2020, Pflegefachassistenz seit November 2022, Umsetzung der neuen Ausbildung nach Landesgesetzgebung
Kooperationspartner für die ASH
Marion Strauss
Patientenfürsprecherin KAU
Dieffenbachstraße 1
10967 Berlin
Phone:
030
-13022-0031
Mail:
ed.nilreb@uak.viv-ftap
K. Runck
Qualitätsmanagerin
Dieffenbachstraße 1
10967 Berlin
Phone:
030
-13022-0210
Mail:
ed.setnaviv@uak.mq
A. Melcher
Qualitätsmanagerin
Dieffenbachstraße 1
10967 Berlin
Phone:
030
-13022-0210
Mail:
ed.setnaviv@uak.mq
Dr. J. Danckert
GF Klinikmanagement
Dieffenbachstraße 1
10967 Berlin
Phone:
030
-13011-
Mail:
ed.setnaviv@ofni
Prof. Dr. Ahmed Magheli
Ärztlicher Direktor
Dieffenbachstraße 1
10967 Berlin
Phone:
030
-13022-6301
Mail:
ed.setnaviv@ilehgam.demha
Dr. U. Zuther
Leitung Vivantes Apotheke Süd
Dieffenbachstraße 1
10967 Berlin
Phone:
030
-13014-2560
Mail:
ed.setnaviv@rehtuz.ekirlu
Ariane Schulze
Leitung Sozialdienst-Somatik
Dieffenbachstraße 1
10967 Berlin
Phone:
030
-13019-2580
Mail:
ed.setnaviv@ezluhcs.enaira
Phone:
030-130-10
Fax:
030-13022-0005
Mail:
ed.setnaviv@ofni
Jeanette Liersch
Pflegedirektorin
Dieffenbachstraße 1
10967 Berlin
Phone:
030
-13022-0201
Mail:
ed.setnaviv@hcsreil.ettenaej
Pia Gabel
Geschäftsführende Direktorin
Dieffenbachstraße 1
10967 Berlin
Phone:
030
-13022-0001
Mail:
ed.setnaviv@lebag.aip
K. Runck
Abteilungsleitung Patiensicherheit und Qualität
Dieffenbachstraße 1
10967 Berlin
Phone:
030
-13011-1405
Mail:
ed.setnaviv@tnemeganamsteatilauq
Prof. Dr. Ahmed Magheli
Ärztlicher Direktor
Dieffenbachstraße 1
10967 Berlin
Phone:
030
-13022-6301
Mail:
ed.setnaviv@ilehgam.demha
IK: 261101878
Location number: 773181000
Old location number: 773181000